The skincare brand, founded in 1993, is known for its pioneering use of copper peptides and proprietary formulations. Transitioning from a retail-heavy model to a direct-to-consumer (DTC) operation, the company has enhanced margins and strengthened customer data ownership. With a significant annual revenue of approximately $1.0 million and an EBITDA of $300,000, the brand is preparing for a 100% sale, appealing to existing beauty platforms or operators wanting to leverage the brand's cash flow and expand marketing or distribution. Key investment highlights include the brand's long-standing market recognition, proprietary technology, and strong customer retention, boasting an 83.75% retention rate. With dermatologist-tested and award-winning products, the brand was previously endorsed by prestigious retailers. It also has a robust owned marketing channel, comprising over 140,000 email subscribers and 18,000 SMS opt-ins. The formulas are developed to meet EU standards, paving the way for international expansion. The company has successfully captured a loyal, affluent, primarily middle-aged female customer base, with ample opportunity to target younger demographics with preventive solutions. The asset-light model relies on outsourced manufacturing, and the business's operations are managed efficiently with owner-operated financial discretion. Financial metrics reveal an EBITDA margin of 30%. Growth opportunities include expanding digital marketing, extending the product line, targeting younger demographics, focusing on international distribution, and monetizing proprietary formulations through licensing. The business is appealing for strategic buyers or experienced operators seeking a stable brand with positive cash flow potential.